JPRN-jRCT2080221056未知1 期
PhaseI study with multiple, ascending doses of NA808 in patients with chronic hepatitis C viral infection.
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 70age old（—）
- 性别
- All
入选标准
- •Subject shows detectable HCV RNA and has no clinically significant disorders.
- •Male or female of no child-bearing potential
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Phase I/II study investigating increasing doses of bevacizumab in patients with malignant effusioMalignant effusion in cancer patients requiring frequent centesis, at least two within six weeksEUCTR2006-003230-15-ATniversity Clinic Internal Medicine I
进行中（未招募）
1 期
A clinical gene therapy study with hematopoietic stem cells for the treatment of patients suffering from a malignant neoplasm of the central nervous systemGlioblastoma MultiformeEUCTR2018-001404-11-ITGENENTA SCIENCE SR21
进行中（未招募）
不适用
A prospective phase II study on dose escalation using PET based adaptive IMRT stage II-III non small lung cancerStage II-III Non small lung cancerEUCTR2011-003124-12-BECliniques Universitaires Saint Luc
招募中
1 期
A Phase 1 Single and Multiple Ascending Dose Study to Assess the Safety and Pharmacokinetics of SZN-043, a Novel Bispecific Fusion Protein Targeting ASGR1 and ZNRF3/RNF43, in Healthy Volunteers and Subjects with Liver CirrhosisAlcoholic HepatitisInflammatory and Immune System - Other inflammatory or immune system disordersLiver CirrhosisACTRN12622000392763Surrozen Operating, Inc.40
进行中（未招募）
1 期
Cell therapy clinical trial of BOXR1030 in GPC3 positive liver, squamous lung, Merkel cell cancer, and myxoid/round cell liposarcomaCancerISRCTN15110275SOTIO Biotech Inc98